{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:30:37Z","timestamp":1792668637821,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bbmt.2019.06.033","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:31:33Z","timestamp":1562239893000},"page":"2160-2166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903\/AMC-080 Trial"],"prefix":"10.1016","volume":"25","author":[{"given":"Richard F.","family":"Ambinder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday R.","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-3539","authenticated-orcid":false,"given":"Deborah K.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-4837","authenticated-orcid":false,"given":"Joshua","family":"Cyktor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Mellors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Noy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Arce-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Shaughnessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sproat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willis H.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Alvarnas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.06.033_bib0001","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0002","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/asheducation-2013.1.382","article-title":"Update on the treatment of HIV-associated hematologic malignancies","volume":"2013","author":"Little","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0003","first-page":"1100","article-title":"High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease","volume":"89","author":"Gabarre","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0004","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2010.03.019","article-title":"HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)","volume":"16","author":"Krishnan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2009-02-202762","article-title":"High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors","volume":"114","author":"Re","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0006","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.exphem.2004.12.008","article-title":"HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation","volume":"33","author":"Serrano","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0007","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood-2015-08-664706","article-title":"Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803\/AMC 071 trial","volume":"128","author":"Alvarnas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0008","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0009","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5Delta32\/Delta32 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2019.06.033_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0011","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/infdis\/jit086","article-title":"Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation","volume":"207","author":"Henrich","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0012","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbmt.2015.08.006","article-title":"Safety and efficacy of combination antiretroviral therapy in human immunodeficiency virus-infected adults undergoing autologous or allogeneic hematopoietic cell transplantation for hematologic malignancies","volume":"22","author":"Johnston","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0013","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1182\/blood-2009-06-229666","article-title":"Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: yes, we can","volume":"114","author":"Hamadani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0014","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbmt.2009.03.023","article-title":"Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Gupta","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciy010","article-title":"Epidemiology and outcomes of hematopoietic stem cell transplantation in human immunodeficiency virus-positive patients from 1998 to 2012: a nationwide analysis","volume":"67","author":"Mehta","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0016","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0017","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/JCM.02904-15","article-title":"Novel assays for measurement of total cell-associated HIV-1 DNA and RNA","volume":"54","author":"Hong","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0018","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003398","article-title":"Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay","volume":"9","author":"Laird","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-1-4939-3046-3_16","article-title":"Measuring the frequency of latent HIV-1 in resting CD4(+) T cells using a limiting dilution coculture assay","volume":"1354","author":"Laird","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0021","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bbmt.2007.08.047","article-title":"A scheme for defining cause of death and its application in the T cell depletion trial","volume":"13","author":"Copelan","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0022","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0023","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1200\/JCO.2013.54.0625","article-title":"Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning","volume":"32","author":"Kanakry","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0024","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbmt.2019.06.033_bib0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/cid\/ciy565","article-title":"Rapid rebound of a preexisting CXCR4-tropic human immunodeficiency virus variant after allogeneic transplantation with CCR5 \u039432 homozygous stem cells","volume":"68","author":"Verheyen","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002461","article-title":"Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study","volume":"14","author":"Cummins","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0027","first-page":"328","article-title":"Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in 3 HIV-infected individuals","volume":"75","author":"Koelsch","year":"2017","journal-title":"JAIDS"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0028","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2352-3018(15)00248-9","article-title":"Ethics of ART interruption after stem-cell transplantation","volume":"3","author":"Sugarman","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.bbmt.2019.06.033_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005535","article-title":"Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV","volume":"12","author":"Hill","year":"2016","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.bbmt.2019.06.033_bib0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/M18-0759","article-title":"Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann Intern Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119304173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:06:03Z","timestamp":1761059163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119304173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1083879119304173"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.033","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903\/AMC-080 Trial","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}